Philipp Ivanyi

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Phenotyping Established Chronic Lung Allograft Dysfunction Predicts Extracorporeal Photopheresis Response in Lung Transplant Patients

Mark Greer, M. Dierich, Claudia de Wall et al. · American Journal of Transplantation · 2013 · 101 citations · Full text

Lung Transplantation, Transplantation Surgery, Transplantation +11

<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz et al. · Journal of Clinical Oncology · 2024 · 95 citations · Full text

Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

Viktor Grünwald, Annika Karch, Markus K. Schuler et al. · Journal of Clinical Oncology · 2020 · 87 citations

Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib

Viktor Gruenwald, Gernot Beutel, Susanne Schuch-Jantsch et al. · BMC Cancer · 2010 · 65 citations · Full text